Shoreline Biosciences Stock
Shoreline Biosciences is a biotechnology company harnessing the power of induced pluripotent stem cells (iPSCs) for the development of next-generation cell therapies. The company specializes in differentiation techniques, driving iPSCs into highly specific, mature cell types like macrophages and natural killer cells.
For more Shoreline Biosciences stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Kleanthis Xanthpoulos, Ph.D. Chairman and |
| Mauro Avanzi, MD, Ph.D. Chief Medical Officer |
| Charles Calderaro III CTO |
| Scott Forrest, Ph.D. Chief Business Officer |
| Robert Hollingsworth, Ph.D. Chief Scientific Officer |
| Vanessa Jacoby CFO |
